| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.001 |